... Okeke was the lead author of a recent study that found the rate of new high blood pressure diagnoses in people with HIV increased between 1996 and 2013.To successfully stave off heart disease and stroke in patients with HIV, Okeke's study said it was important for doctors to diagnose HIV early and to aggressively treat high blood pressure and other ...
The Link Between HIV and High Blood Pressure
... Okeke was the lead author of a recent study that found the rate of new high blood pressure diagnoses in people with HIV increased between 1996 and 2013.To successfully stave off heart disease and stroke in patients with HIV, Okeke's study said it was important for doctors to diagnose HIV early and to aggressively treat high blood pressure and other ...
... "For those who have exhausted their current [drug] regimen, we now have another hope," the study's senior author, Dr. Stanley Lewis, said of the new drug. He's chief medical officer for TaiMed Biologics, maker of the drug and sponsor of the trial."HIV is probably the most dynamic pathogen in medicine. ...
New Drug of Last Resort Tackles Resistant HIV
... "For those who have exhausted their current [drug] regimen, we now have another hope," the study's senior author, Dr. Stanley Lewis, said of the new drug. He's chief medical officer for TaiMed Biologics, maker of the drug and sponsor of the trial."HIV is probably the most dynamic pathogen in medicine. ...
... "Theoretically, the goal is to provide a lifelong immunity to HIV," said study co-author Scott Kitchen, of the University of California, Los Angeles, School of Medicine."We're aiming for a cure," he said. "And we know that to cure HIV you need an effective immune response, which is what we're seeing here." ...
Could Gene Therapy Someday Eliminate HIV?
... "Theoretically, the goal is to provide a lifelong immunity to HIV," said study co-author Scott Kitchen, of the University of California, Los Angeles, School of Medicine."We're aiming for a cure," he said. "And we know that to cure HIV you need an effective immune response, which is what we're seeing here." ...
... Food and Drug Administration Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting — Cannabis and Cannabinoid Research Cannabidiol (CBD) in Cancer Management — Cancers Anxiety — Medical Cannabis and CBD in Mental Healthcare Cannabidiol Adverse Effects and Toxicity — Current ...
CBD for HIV: Is It Effective?
... Food and Drug Administration Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting — Cannabis and Cannabinoid Research Cannabidiol (CBD) in Cancer Management — Cancers Anxiety — Medical Cannabis and CBD in Mental Healthcare Cannabidiol Adverse Effects and Toxicity — Current ...
... For example, some ART drugs, like atazanavir (Reyataz) and rilpivirine (Edurant), need high levels of stomach acid for proper absorption. Because GLP-1 receptor agonists can reduce the release of this acid, they might affect how well these ART drugs work. ...
GLP-1 Drugs and HIV: Is It Safe To Take Them With Your Meds?
... For example, some ART drugs, like atazanavir (Reyataz) and rilpivirine (Edurant), need high levels of stomach acid for proper absorption. Because GLP-1 receptor agonists can reduce the release of this acid, they might affect how well these ART drugs work. ...
... The window period is 18 days to 90 days for a rapid antibody/antigen test and 18 days to 45 days for an antibody/antigen laboratory test.A nonreactive antibody/antigen test means that the test did not detect HIV antibodies or HIV antigens in your blood sample.Nucleic Acid TestsAlso known as viral load tests, NATs look directly for HIV and can tell how ...
What Does a Nonreactive HIV Test Mean? Understanding Your Results
... The window period is 18 days to 90 days for a rapid antibody/antigen test and 18 days to 45 days for an antibody/antigen laboratory test.A nonreactive antibody/antigen test means that the test did not detect HIV antibodies or HIV antigens in your blood sample.Nucleic Acid TestsAlso known as viral load tests, NATs look directly for HIV and can tell how ...
... One test that should be considered for people suspected to have recent exposure or acute HIV symptoms is the nucleic acid test (NAT). NATs measure the amount of virus in the blood and can detect HIV as early as 10 to 33 days after exposure.Antibody and antigen/antibody tests are also available. ...
HIV Sore Throat: Is It an Early Symptom of Infection?
... One test that should be considered for people suspected to have recent exposure or acute HIV symptoms is the nucleic acid test (NAT). NATs measure the amount of virus in the blood and can detect HIV as early as 10 to 33 days after exposure.Antibody and antigen/antibody tests are also available. ...
... For example, rilpivirine — a component of many newer HIV combinations — should be taken several hours apart from certain medications used to treat heartburn or acid reflux.Speak to Your Health Care Team Deciding on the best strategies to take your HIV medications can be complicated. ...
HIV Treatment Goals: The Best Time To Take Your Pill
... For example, rilpivirine — a component of many newer HIV combinations — should be taken several hours apart from certain medications used to treat heartburn or acid reflux.Speak to Your Health Care Team Deciding on the best strategies to take your HIV medications can be complicated. ...
... This is done by testing for HIV-1 genetic material (RNA) with a nucleic acid amplification test (NAAT). However, an HIV-2 NAAT is not routinely available to test for HIV-2, and further testing may be needed if a person is at risk for this infection.Diagnosing HIV-1 and HIV-2 infection is recommended by the testing sequence just mentioned. ...
HIV-1 vs. HIV-2: What Are The Differences and Can You Have Both?
... This is done by testing for HIV-1 genetic material (RNA) with a nucleic acid amplification test (NAAT). However, an HIV-2 NAAT is not routinely available to test for HIV-2, and further testing may be needed if a person is at risk for this infection.Diagnosing HIV-1 and HIV-2 infection is recommended by the testing sequence just mentioned. ...
... For that reason, this medication isn’t recommended for people who already have heart conditions or a higher risk of cardiovascular disease.Rarely, NRTIs like abacavir can cause two specific conditions — lactic acidosis (lactic acid buildup in the blood) and steatosis (fatty liver disease). ...
Abacavir and Lamivudine: Why They’re Used Together
... For that reason, this medication isn’t recommended for people who already have heart conditions or a higher risk of cardiovascular disease.Rarely, NRTIs like abacavir can cause two specific conditions — lactic acidosis (lactic acid buildup in the blood) and steatosis (fatty liver disease). ...
Join
